Overall, our studies strongly demonstrated that CHI3L1 and its receptors play an important role in mediating pulmonary injury and repair in HPS, and targeting these moieties may provide novel and effective therapeutic options. The gene discussed is CHI3L1; the disease is Hermansky-Pudlak syndrome.